




{"id":6151,"date":"2022-05-01T06:30:00","date_gmt":"2022-05-01T06:30:00","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/realheart-slapper-arsredovisningen-for-2021\/"},"modified":"2022-05-01T06:30:00","modified_gmt":"2022-05-01T06:30:00","slug":"realheart-slapper-arsredovisningen-for-2021","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/realheart-slapper-arsredovisningen-for-2021\/","title":{"rendered":"Realheart sl\u00e4pper \u00e5rsredovisningen f\u00f6r 2021"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>Pressmeddelande 2022-05-01<\/strong><\/div>\n<p><span><span><span><span>Idag publicerar Realheart \u00e5rsredovisningen f\u00f6r 2021. En layoutad version med reportage, samarbeten och milstolpar under \u00e5ret sl\u00e4pps i samband med kallelsen till \u00e5rsst\u00e4mman som ber\u00e4knas g\u00e5 ut den 11 maj 2022.<\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span>Hela \u00e5rsredovisningen samt revisionsber\u00e4ttelsen finns tillg\u00e4ngliga p\u00e5 bolagets <span>hemsida,\u00a0<\/span><a href=\"http:\/\/www.realheart.se\/\" rel=\"nofollow\"><span>www.realheart.se<\/span><\/a><span>\u00a0och som bilaga i detta pressmeddelande.<\/span><\/span><\/span><\/span><\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><strong>F\u00f6r ytterligare information kontakta:<\/strong><\/span><\/p>\n<p><span>Ina Laura Perkins, VD <\/span><\/p>\n<p><span>Tel: +46(0)70 406 49 21<\/span><\/p>\n<p><span>E-post: <a href=\"mailto:inalaura.perkins@realheart.se\" rel=\"nofollow\">inalaura.perkins@realheart.se<\/a><\/span><\/p>\n<p><span>Certified Adviser: Svensk Kapitalmarknadsgranskning AB, Telefon: +46 11 32 30\u00a0732, email:\u00a0<a href=\"mailto:ca@skmg.se\" rel=\"nofollow\">ca@skmg.se<\/a><\/span><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><span><em>Scandinavian Real Heart AB utvecklar ett komplett artificiellt hj\u00e4rta (Total Artificial Heart \u2013 TAH) f\u00f6r implantation i patienter med livshotande hj\u00e4rtsvikt. Bolagets TAH har en unik, patenterad, design som innefattar en kopiering av det naturliga m\u00e4nskliga hj\u00e4rtat. Real Hearts TAH inf\u00f6rlivar ett fyrkammarsystem (tv\u00e5 f\u00f6rmak, tv\u00e5 kamrar) vilket ger m\u00f6jlighet att generera ett fysiologiskt anpassat blodfl\u00f6de som efterliknar kroppens naturliga cirkulation. Ett koncept som \u00e4r unikt i den medicintekniska v\u00e4rlden. <\/em><em><\/em><\/span><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/ar-scandinavian-real-heart-2021-signerad.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F3556652%2F1571777.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/ar-scandinavian-real-heart-2021-signerad.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F3556652%2F1571777.pdf&type=jpg\"><\/span>A\u030aR Scandinavian Real Heart 2021 signerad<\/a><\/div><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/rb-scandinavian-real-heart-2021.pdf?url=https%3A%2F%2Fmb.cision.com%2FPublic%2F12118%2F3556652%2F88b096ec6e29211d.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/rb-scandinavian-real-heart-2021.pdf?url=https%3A%2F%2Fmb.cision.com%2FPublic%2F12118%2F3556652%2F88b096ec6e29211d.pdf&type=jpg\"><\/span>RB Scandinavian Real Heart 2021<\/a><\/div><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/realheart-sla-pper-a-rsredovisningen-fo-r-2021.pdf?url=https%3A%2F%2Fmb.cision.com%2FPublic%2F12118%2F3556652%2F972389806a97dbdb.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/realheart-sla-pper-a-rsredovisningen-fo-r-2021.pdf?url=https%3A%2F%2Fmb.cision.com%2FPublic%2F12118%2F3556652%2F972389806a97dbdb.pdf&type=jpg\"><\/span>Realheart sla pper A rsredovisningen fo r 2021<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Pressmeddelande 2022-05-01 Idag publicerar Realheart \u00e5rsredovisningen f\u00f6r 2021. En layoutad version med reportage, samarbeten och milstolpar under \u00e5ret sl\u00e4pps i samband med kallelsen till \u00e5rsst\u00e4mman som ber\u00e4knas g\u00e5 ut den 11 maj 2022. Hela \u00e5rsredovisningen samt revisionsber\u00e4ttelsen finns tillg\u00e4ngliga p\u00e5 bolagets hemsida,\u00a0www.realheart.se\u00a0och som bilaga i detta pressmeddelande. F\u00f6r ytterligare information kontakta: Ina Laura Perkins, VD&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-6151","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-report-annual","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory-vpml"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Realheart sl\u00e4pper \u00e5rsredovisningen f\u00f6r 2021 - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/mfn_news\/realheart-slapper-arsredovisningen-for-2021\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Realheart sl\u00e4pper \u00e5rsredovisningen f\u00f6r 2021 - Realheart\" \/>\n<meta property=\"og:description\" content=\"Pressmeddelande 2022-05-01 Idag publicerar Realheart \u00e5rsredovisningen f\u00f6r 2021. En layoutad version med reportage, samarbeten och milstolpar under \u00e5ret sl\u00e4pps i samband med kallelsen till \u00e5rsst\u00e4mman som ber\u00e4knas g\u00e5 ut den 11 maj 2022. Hela \u00e5rsredovisningen samt revisionsber\u00e4ttelsen finns tillg\u00e4ngliga p\u00e5 bolagets hemsida,\u00a0www.realheart.se\u00a0och som bilaga i detta pressmeddelande. F\u00f6r ytterligare information kontakta: Ina Laura Perkins, VD...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/mfn_news\/realheart-slapper-arsredovisningen-for-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-slapper-arsredovisningen-for-2021\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-slapper-arsredovisningen-for-2021\\\/\",\"name\":\"Realheart sl\u00e4pper \u00e5rsredovisningen f\u00f6r 2021 - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"datePublished\":\"2022-05-01T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-slapper-arsredovisningen-for-2021\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-slapper-arsredovisningen-for-2021\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-slapper-arsredovisningen-for-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Realheart sl\u00e4pper \u00e5rsredovisningen f\u00f6r 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Realheart sl\u00e4pper \u00e5rsredovisningen f\u00f6r 2021 - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/mfn_news\/realheart-slapper-arsredovisningen-for-2021\/","og_locale":"sv_SE","og_type":"article","og_title":"Realheart sl\u00e4pper \u00e5rsredovisningen f\u00f6r 2021 - Realheart","og_description":"Pressmeddelande 2022-05-01 Idag publicerar Realheart \u00e5rsredovisningen f\u00f6r 2021. En layoutad version med reportage, samarbeten och milstolpar under \u00e5ret sl\u00e4pps i samband med kallelsen till \u00e5rsst\u00e4mman som ber\u00e4knas g\u00e5 ut den 11 maj 2022. Hela \u00e5rsredovisningen samt revisionsber\u00e4ttelsen finns tillg\u00e4ngliga p\u00e5 bolagets hemsida,\u00a0www.realheart.se\u00a0och som bilaga i detta pressmeddelande. F\u00f6r ytterligare information kontakta: Ina Laura Perkins, VD...","og_url":"https:\/\/realheart.se\/mfn_news\/realheart-slapper-arsredovisningen-for-2021\/","og_site_name":"Realheart","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/mfn_news\/realheart-slapper-arsredovisningen-for-2021\/","url":"https:\/\/realheart.se\/mfn_news\/realheart-slapper-arsredovisningen-for-2021\/","name":"Realheart sl\u00e4pper \u00e5rsredovisningen f\u00f6r 2021 - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"datePublished":"2022-05-01T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/realheart.se\/mfn_news\/realheart-slapper-arsredovisningen-for-2021\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/mfn_news\/realheart-slapper-arsredovisningen-for-2021\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/mfn_news\/realheart-slapper-arsredovisningen-for-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"MFN News Items","item":"https:\/\/realheart.se\/mfn_news\/"},{"@type":"ListItem","position":2,"name":"Realheart sl\u00e4pper \u00e5rsredovisningen f\u00f6r 2021"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news\/6151","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=6151"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}